Literature DB >> 15017191

Rapid elimination by glomerular filtration of free prostate specific antigen and human kallikrein 2 after renal transplantation.

Laila Bruun1, Henrik Ekberg, Thomas Bjørk, Hans Lilja, Peter Høglund, Anders Christensson.   

Abstract

PURPOSE: The low molecular mass and short half-life of free (f) prostate specific antigen (PSA) implies elimination from blood by glomerular filtration. In addition, patients with terminal renal failure have increased fPSA in serum but there have been sparse data reported on the rates and pathways of elimination of PSA complexes and human kallikrein 2 (hK2). We studied glomerular filtration dependent elimination of fPSA and hK2 in patients with renal insufficiency undergoing successful renal transplantation.
MATERIALS AND METHODS: We studied 14 patients with immediate onset of renal function after renal transplantation. Blood samples were obtained before and at regular intervals up to 160 hours after transplanted kidney reperfusion. Measurements of fPSA, total PSA and hK2 were performed with immunofluorometric assays and complexed PSA was determined by a chemiluminiscence assay. Glomerular filtration rates were monitored by analyzing serum creatinine and cystatin C. NONMEM, a multivariate pharmacokinetic approach, was used to determine the elimination rates of fPSA and hK2 after renal transplantation.
RESULTS: Serum fPSA and hK2 but not PSA complexes, decreased rapidly after renal transplantation. Significant reductions in fPSA and hK2 were observed after only 16 and 8 hours, respectively. fPSA and hK2 showed similar elimination patterns, decreasing to 42% and 44% of their original levels compared to cystatin C, which was at 44% after 160 hours. The median half-lives of fPSA and hK2 were 17.4 and 11.5 hours, respectively.
CONCLUSIONS: These results verify the hypothesis that fPSA and hK2 are eliminated from the blood circulation by glomerular filtration and severe renal failure influences the levels of the 2 proteins in serum.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15017191     DOI: 10.1097/01.ju.0000118580.19344.68

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  11 in total

1.  Editorial comment. Association between glomerular filtration rate, free, total, and percent free prostate-specific antigen.

Authors:  Anders Christensson; Hans Lilja
Journal:  Urology       Date:  2010-11       Impact factor: 2.649

2.  Age-Specific Reference Ranges of Prostate-Specific Antigen among Saudi Men as a Representation of the Arab Population.

Authors:  Danny Munther Rabah; Karim Hamda Farhat; Mohamed Abdullah Al-Atawi; Mostafa Ahmed Arafa
Journal:  Med Princ Pract       Date:  2019-02-07       Impact factor: 1.927

3.  Rapid elimination kinetics of free PSA or human kallikrein-related peptidase 2 after initiation of gonadotropin-releasing hormone-antagonist treatment of prostate cancer: potential for rapid monitoring of treatment responses.

Authors:  David Ulmert; Andrew J Vickers; Howard I Scher; Charlotte Becker; Peter Iversen; David Frankel; Jens-Kristian Jensen; Tine Kold Olesen; Hans Lilja
Journal:  Clin Chem Lab Med       Date:  2012-11       Impact factor: 3.694

4.  Targeting free prostate-specific antigen for in vivo imaging of prostate cancer using a monoclonal antibody specific for unique epitopes accessible on free prostate-specific antigen alone.

Authors:  Susan Evans-Axelsson; David Ulmert; Anders Örbom; Pernilla Peterson; Olle Nilsson; Johan Wennerberg; Joanna Strand; Karin Wingårdh; Tomas Olsson; Zandra Hagman; Vladimir Tolmachev; Anders Bjartell; Hans Lilja; Sven-Erik Strand
Journal:  Cancer Biother Radiopharm       Date:  2012-04-10       Impact factor: 3.099

5.  Assessment of intra-individual variation in prostate-specific antigen levels in a biennial randomized prostate cancer screening program in Sweden.

Authors:  Laila Bruun; Charlotte Becker; Jonas Hugosson; Hans Lilja; Anders Christensson
Journal:  Prostate       Date:  2005-11-01       Impact factor: 4.104

6.  The effect of sirolimus on prostate-specific antigen (PSA) levels in male renal transplant recipients without prostate cancer.

Authors:  K Chamie; P M Ghosh; T M Koppie; V Romero; C Troppmann; R W deVere White
Journal:  Am J Transplant       Date:  2008-10-06       Impact factor: 8.086

7.  Association between percent-free prostate-specific antigen and glomerular filtration rate in transrectal ultrasound-guided biopsy-proven patients with prostate-specific antigen levels ranging from 4 to 10 ng/ml.

Authors:  Jae Heon Kim; Ji Sung Shim; Jae Hyun Bae; Hong Seok Park; Du Geon Moon; Soon-Sun Kwon; Jae Young Park
Journal:  World J Urol       Date:  2013-01-03       Impact factor: 4.226

8.  Increase in percent free prostate-specific antigen in men with chronic kidney disease.

Authors:  Laila Bruun; Caroline Savage; Angel M Cronin; Jonas Hugosson; Hans Lilja; Anders Christensson
Journal:  Nephrol Dial Transplant       Date:  2008-11-21       Impact factor: 5.992

Review 9.  Tumour markers and kidney function: a systematic review.

Authors:  Giuseppe Coppolino; Davide Bolignano; Laura Rivoli; Giuseppe Mazza; Piera Presta; Giorgio Fuiano
Journal:  Biomed Res Int       Date:  2014-02-06       Impact factor: 3.411

10.  Studying the effect of type 2 diabetes mellitus on prostate-related parameters: A prospective single institutional study.

Authors:  Ahmed Elabbady; Mohamed M Hashad; Ahmed F Kotb; Ali E Ghanem
Journal:  Prostate Int       Date:  2016-08-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.